Literature DB >> 33764982

Identifying optimal COVID-19 testing strategies for schools and businesses: Balancing testing frequency, individual test technology, and cost.

Gregory D Lyng1, Natalie E Sheils1, Caleb J Kennedy1, Daniel O Griffin2,3, Ethan M Berke1.   

Abstract

BACKGROUND: COVID-19 test sensitivity and specificity have been widely examined and discussed, yet optimal use of these tests will depend on the goals of testing, the population or setting, and the anticipated underlying disease prevalence. We model various combinations of key variables to identify and compare a range of effective and practical surveillance strategies for schools and businesses.
METHODS: We coupled a simulated data set incorporating actual community prevalence and test performance characteristics to a susceptible, infectious, removed (SIR) compartmental model, modeling the impact of base and tunable variables including test sensitivity, testing frequency, results lag, sample pooling, disease prevalence, externally-acquired infections, symptom checking, and test cost on outcomes including case reduction and false positives.
FINDINGS: Increasing testing frequency was associated with a non-linear positive effect on cases averted over 100 days. While precise reductions in cumulative number of infections depended on community disease prevalence, testing every 3 days versus every 14 days (even with a lower sensitivity test) reduces the disease burden substantially. Pooling provided cost savings and made a high-frequency approach practical; one high-performing strategy, testing every 3 days, yielded per person per day costs as low as $1.32.
INTERPRETATION: A range of practically viable testing strategies emerged for schools and businesses. Key characteristics of these strategies include high frequency testing with a moderate or high sensitivity test and minimal results delay. Sample pooling allowed for operational efficiency and cost savings with minimal loss of model performance.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33764982      PMCID: PMC7993807          DOI: 10.1371/journal.pone.0248783

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  24 in total

1.  COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.

Authors:  Robert D Kirkcaldy; Brian A King; John T Brooks
Journal:  JAMA       Date:  2020-06-09       Impact factor: 56.272

2.  The Right Kind of Pooled Testing for the Novel Coronavirus: First, Do No Harm.

Authors:  Eugene Litvak; Susan Dentzer; Marcello Pagano
Journal:  Am J Public Health       Date:  2020-09-24       Impact factor: 9.308

3.  Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens.

Authors:  Wei Zhen; Ryhana Manji; Elizabeth Smith; Gregory J Berry
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

4.  Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China.

Authors:  Jinru Wu; Xinyi Liu; Jianjun Liu; Han Liao; Sixuan Long; Ning Zhou; Pa Wu
Journal:  JAMA Netw Open       Date:  2020-05-01

5.  The relative transmissibility of asymptomatic COVID-19 infections among close contacts.

Authors:  Daihai He; Shi Zhao; Qianying Lin; Zian Zhuang; Peihua Cao; Maggie H Wang; Lin Yang
Journal:  Int J Infect Dis       Date:  2020-04-18       Impact factor: 3.623

6.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

7.  Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources.

Authors:  Baha Abdalhamid; Christopher R Bilder; Emily L McCutchen; Steven H Hinrichs; Scott A Koepsell; Peter C Iwen
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

8.  Optimizing COVID-19 surveillance in long-term care facilities: a modelling study.

Authors:  David R M Smith; Audrey Duval; Koen B Pouwels; Didier Guillemot; Jérôme Fernandes; Bich-Tram Huynh; Laura Temime; Lulla Opatowski
Journal:  BMC Med       Date:  2020-12-08       Impact factor: 8.775

9.  SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.

Authors:  Victor M Corman; Holger F Rabenau; Ortwin Adams; Doris Oberle; Markus B Funk; Brigitte Keller-Stanislawski; Jörg Timm; Christian Drosten; Sandra Ciesek
Journal:  Transfusion       Date:  2020-05-27       Impact factor: 3.337

10.  Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays.

Authors:  Antonio La Marca; Martina Capuzzo; Tiziana Paglia; Laura Roli; Tommaso Trenti; Scott M Nelson
Journal:  Reprod Biomed Online       Date:  2020-06-14       Impact factor: 3.828

View more
  12 in total

1.  Proposal of Smith-Waterman algorithm on FPGA to accelerate the forward and backtracking steps.

Authors:  Fabio F de Oliveira; Leonardo A Dias; Marcelo A C Fernandes
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

Review 2.  Measures implemented in the school setting to contain the COVID-19 pandemic

Authors:  Shari Krishnaratne; Hannah Littlecott; Kerstin Sell; Jacob Burns; Julia E Rabe; Jan M Stratil; Tim Litwin; Clemens Kreutz; Michaela Coenen; Karin Geffert; Anna Helen Boger; Ani Movsisyan; Suzie Kratzer; Carmen Klinger; Katharina Wabnitz; Brigitte Strahwald; Ben Verboom; Eva Rehfuess; Renke L Biallas; Caroline Jung-Sievers; Stephan Voss; Lisa M Pfadenhauer
Journal:  Cochrane Database Syst Rev       Date:  2022-01-17

3.  Detection of SARS-CoV-2 RNA using RT-LAMP and molecular beacons.

Authors:  Scott Sherrill-Mix; Young Hwang; Aoife M Roche; Abigail Glascock; Susan R Weiss; Yize Li; Leila Haddad; Peter Deraska; Caitlin Monahan; Andrew Kromer; Jevon Graham-Wooten; Louis J Taylor; Benjamin S Abella; Arupa Ganguly; Ronald G Collman; Gregory D Van Duyne; Frederic D Bushman
Journal:  Genome Biol       Date:  2021-06-03       Impact factor: 13.583

4.  Pooling saliva samples as an excellent option to increase the surveillance for SARS-CoV-2 when re-opening community settings.

Authors:  Joaquín Moreno-Contreras; Marco A Espinoza; Carlos Sandoval-Jaime; Marco A Cantú-Cuevas; Daniel A Madrid-González; Héctor Barón-Olivares; Oscar D Ortiz-Orozco; Asunción V Muñoz-Rangel; Cecilia Guzmán-Rodríguez; Manuel Hernández-de la Cruz; César M Eroza-Osorio; Carlos F Arias; Susana López
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

5.  Modeling for COVID-19 college reopening decisions: Cornell, a case study.

Authors:  Peter I Frazier; J Massey Cashore; Ning Duan; Shane G Henderson; Alyf Janmohamed; Brian Liu; David B Shmoys; Jiayue Wan; Yujia Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-11       Impact factor: 11.205

6.  Comparison of high-frequency in-pipe SARS-CoV-2 wastewater-based surveillance to concurrent COVID-19 random clinical testing on a public U.S. university campus.

Authors:  Jillian Wright; Erin M Driver; Devin A Bowes; Bridger Johnston; Rolf U Halden
Journal:  Sci Total Environ       Date:  2022-01-06       Impact factor: 10.753

7.  On an optimal testing strategy for workplace settings operating during the COVID-19 pandemic.

Authors:  X Hernandez; S Valentinotti
Journal:  PLoS One       Date:  2022-03-02       Impact factor: 3.240

8.  The effect of the Ontario stay-at-home order on Covid-19 third wave infections including vaccination considerations: An interrupted time series analysis.

Authors:  Fatemeh Navazi; Yufei Yuan; Norm Archer
Journal:  PLoS One       Date:  2022-04-06       Impact factor: 3.240

9.  Designing optimal COVID-19 testing stations locally: A discrete event simulation model applied on a university campus.

Authors:  Michael Saidani; Harrison Kim; Jinju Kim
Journal:  PLoS One       Date:  2021-06-29       Impact factor: 3.240

Review 10.  Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review.

Authors:  Le Minh Bui; Huong Thi Thu Phung; Thuy-Tien Ho Thi; Vijai Singh; Rupesh Maurya; Khushal Khambhati; Chia-Ching Wu; Md Jamal Uddin; Do Minh Trung; Dinh Toi Chu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.